The Procter & Gamble Company (NYSE:PG) Shares Sold by Central Bank & Trust Co.

Central Bank & Trust Co. trimmed its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 8.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 12,898 shares of the company’s stock after selling 1,151 shares during the quarter. Central Bank & Trust Co.’s holdings in Procter & Gamble were worth $2,234,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in the business. Welch Group LLC boosted its position in shares of Procter & Gamble by 0.9% in the 3rd quarter. Welch Group LLC now owns 323,870 shares of the company’s stock valued at $56,094,000 after purchasing an additional 2,990 shares during the period. GAMMA Investing LLC boosted its holdings in shares of Procter & Gamble by 67.2% in the second quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock worth $4,420,000 after buying an additional 10,777 shares during the period. AMF Tjanstepension AB raised its holdings in shares of Procter & Gamble by 416.1% during the third quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock valued at $315,016,000 after acquiring an additional 1,466,115 shares during the period. Octavia Wealth Advisors LLC grew its position in Procter & Gamble by 51.3% during the 2nd quarter. Octavia Wealth Advisors LLC now owns 59,647 shares of the company’s stock worth $9,837,000 after purchasing an additional 20,218 shares in the last quarter. Finally, Mystic Asset Management Inc. boosted its position in Procter & Gamble by 4.1% during the 1st quarter. Mystic Asset Management Inc. now owns 10,107 shares of the company’s stock worth $1,640,000 after acquiring an additional 402 shares during the period. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Price Performance

Shares of NYSE:PG opened at $165.08 on Tuesday. The firm has a market capitalization of $388.77 billion, a PE ratio of 28.46, a PEG ratio of 3.57 and a beta of 0.42. The Procter & Gamble Company has a 1-year low of $142.50 and a 1-year high of $177.94. The business’s 50 day moving average is $171.52 and its 200-day moving average is $168.13. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. During the same quarter in the prior year, the business posted $1.83 earnings per share. The company’s quarterly revenue was down .6% compared to the same quarter last year. Sell-side analysts predict that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a dividend of $1.0065 per share. The ex-dividend date is Friday, October 18th. This represents a $4.03 annualized dividend and a yield of 2.44%. Procter & Gamble’s dividend payout ratio is currently 69.48%.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on PG. StockNews.com cut Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Morgan Stanley boosted their target price on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research report on Monday, October 21st. Stifel Nicolaus raised their price target on shares of Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a report on Monday, July 22nd. Evercore ISI upped their price objective on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a report on Monday, October 21st. Finally, Dbs Bank lowered Procter & Gamble from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 1st. Nine research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $177.00.

Read Our Latest Stock Report on PG

Insider Buying and Selling at Procter & Gamble

In related news, CEO Jon R. Moeller sold 72,174 shares of Procter & Gamble stock in a transaction dated Friday, August 9th. The shares were sold at an average price of $171.01, for a total transaction of $12,342,475.74. Following the completion of the transaction, the chief executive officer now directly owns 263,158 shares of the company’s stock, valued at $45,002,649.58. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, insider Susan Street Whaley sold 450 shares of Procter & Gamble stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total value of $76,149.00. Following the completion of the transaction, the insider now directly owns 13,072 shares of the company’s stock, valued at $2,212,043.84. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Jon R. Moeller sold 72,174 shares of the stock in a transaction dated Friday, August 9th. The stock was sold at an average price of $171.01, for a total transaction of $12,342,475.74. Following the sale, the chief executive officer now directly owns 263,158 shares in the company, valued at approximately $45,002,649.58. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 385,771 shares of company stock valued at $65,610,975. 0.18% of the stock is currently owned by company insiders.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.